Long-Term Bone Density Evaluation in Cerebrotendinous Xanthomatosis: Evidence of Improvement after C...
Long-Term Bone Density Evaluation in Cerebrotendinous Xanthomatosis: Evidence of Improvement after Chenodeoxycholic Acid Treatment
About this item
Full title
Author / Creator
Publisher
New York: Springer-Verlag
Journal title
Language
English
Formats
Publication information
Publisher
New York: Springer-Verlag
Subjects
More information
Scope and Contents
Contents
Cerebrotendinous xanthomatosis (CTX) is known to be associated with osteoporosis and a higher incidence of bone fractures. However, the underlying pathogenesis is still unknown, and the effects of long-term replacement therapy with chenodeoxycholic acid (CDCA) on bone mineral density (BMD) have not been fully investigated. We studied 11 CTX patient...
Alternative Titles
Full title
Long-Term Bone Density Evaluation in Cerebrotendinous Xanthomatosis: Evidence of Improvement after Chenodeoxycholic Acid Treatment
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_miscellaneous_1291605385
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_1291605385
Other Identifiers
ISSN
0171-967X
E-ISSN
1432-0827
DOI
10.1007/s00223-012-9677-3
